What`s New for 2023?

» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Stem Cell Banking Market to Reach $11.5 Billion by 2026

Stem cells are undifferentiated cells that hold the capability to divide, and differentiate into specialized cells in the body. Stem cells act as repair system and replenish adult tissues, maintaining the turnover of regenerative organs such as the blood and skin. In organs, such as the bone marrow, stem cells frequently form replacement cells to repair the worn out tissue. These cells can respond to signals from the body and transverse a particular developmental pathway to differentiate into one specific cell type. Due to their regenerative properties, stem cells are being researched for therapeutic applications in diabetes, cardiovascular disease, neurodegenerative disease, cancer, autoimmune diseases, spinal cord defects, baldness, missing teeth, learning defects, and to restore vision and hearing, among many others. Sources of stem cells in the body include cord blood and placenta, adipose tissue, bone marrow, human embryo, and dental pulp-derived stem cells. Stem cell therapy has significant potential to become a highly regarded therapeutic option in the medical field.

Stem Cell research is an exciting field where there are constant discoveries on new sources of stem cells and new methods of their acquisition and harvesting. Of late, adult stem cells have garnered a lion`s share of the stem cell space, purely based on the fact that they require less expensive clinical trials, need to comply with fewer regulatory norms and ethical issues compared to other stem cell variants such as embryonic stem cells. Researchers around the world have been focusing research activities to develop adult stem cell therapies in order to combat a variety of diseases ranging from diabetes to heart disease. Factually, adult stem cells are the only stem cells that have been approved for use in transplants for the treatment of diseases such as cancers. Adult stem cells are being used for the development of therapeutic procedures that would be useful in the treatment of cartilage defects in children; multiple sclerosis, rheumatoid arthritis and systemic lupus; restoring vision in blind patients; and in numerous cancer therapy procedures.

Amid the COVID-19 crisis, the global market for Stem Cell Banking estimated at US$8.6 Billion in the year 2022, is projected to reach a revised size of US$11.5 Billion by 2026, registering a compounded annual growth rate (CAGR) of 7.6% over the analysis period. The United States represents the largest regional market for Stem Cell Banking, and is projected to reach US$4.3 Billion by 2026. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 10% over the analysis period.

Rapidly rising awareness about the therapeutic capabilities of stem cells, due to the increased availability of clinical evidence, is the primary factor driving growth in the global stem cells banking market. Rapidly rising importance of stem cells in the treatment of more than 80 diseases and growing awareness about the general populace about stem cell therapies and the importance of stem cell banking services are spurring market growth. The growing benefits of stem cells are enhancing the importance of stem cell banks. Driven by advancements in the medical research space, the life expectancy of humans has increased considerably. However, there has been a rise in incidence of various chronic conditions, whereby focus has shifted onto the development of stem cell therapies thus paving the way for high growth in the stem cell banking market. The rising fertility rates and increase in newborns are also presenting significant opportunities due to the potential role of umbilical cord-based stem cells in treatment of various diseases. All of these are in turn necessitating extraction and preservation of stem cells, thus driving growth in the stem cells banking market.

Globally, the incidence of diseases such as cancer, cardiovascular diseases and diabetes among others continues to grow, enhancing the need for extensive and long-term treatments requiring hospitalization and involving significant costs, thus becoming a burden for healthcare systems across the world. Additional costs are often incurred due to potential of relapse in case of certain diseases. The growing burden of diseases, high cost of treatment and the rising need for affordable treatments is presenting growth opportunities for the stem cell industry. Stem cells are currently being utilized for treatment of immune-related and blood disorders such as leukemia. Growth in the global stem cell banking market is being driven by the rapid pace of advancements being witnessed in the regenerative medicine space. As the medical sector focuses on developing artificial tissues capable of integrating with the human body, there is significant focus on medical analysis and testing in research institutes and biological labs. This in turn raises the importance of developing stem cell samples and creating repositories capable of storing stem cell samples for research purposes.

North America and Europe are leading the global stem cell banking market. In the US, rising healthcare costs and increasing need for superior treatment of conditions affecting the aged are emerging as favorable trends driving the growth in the stem cells banking market. Many have begun to see stem cell based therapies as a viable option for tackling the increasing healthcare costs in the country and as a source for addressing unmet needs in the area of medicine. The presence of a large and expanding network of stem cell banks in the region, increase in approvals for stem cells in the treatment of various diseases, and advancements in technologies for collecting and preserving stem cells are favoring growth. Rising investments in stem cell research projects by pharmaceutical and biopharmaceutical companies and increase in stem cell transplants procedures being performed are also sustaining growth in the region. In Europe, the rising prevalence of chronic illnesses such as cancer, growing demand for personalized treatments and medicines, increased focus on R&D related to stem cell applications, and establishment of high-tech stem cell research labs are all contributing to the growth of stem cell banking market in the region. Aging population is likely to emerge as a significant driver of future growth in the European stem cell banking market. Emerging markets across Asia Pacific, Latin America, and Middle East & Africa are poised to offer significant potential for growth of stem cell banks, due to the rapid growth of healthcare services in the regions and the vast patient population. Growing investments being made by regional governments especially in China and India to enhance healthcare services will also drive opportunities for the stem cell banking market.